Generic placeholder image

Current Pediatric Reviews

Author(s): Giuseppe De Bernardo*, Valeria Crisci, Fabio Centanni, Maurizio Giordano, Serafina Perrone, Giuseppe Buonocore and Claudia Mandato

DOI: 10.2174/0115733963328784240820062714

DownloadDownload PDF Flyer Cite As
Laryngeal Mask for Minimally-invasive Surfactant Administration: A Narrative Review

Page: [111 - 117] Pages: 7

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

The cornerstone of treatment for respiratory distress syndrome in preterm infants is surfactant administration, traditionally performed through an invasive procedure involving tracheal intubation and mechanical ventilation. Consequently, there has been a growing interest in exploring less invasive methods of surfactant delivery to mitigate the associated risks. Currently, several techniques are under evaluation, including intratracheal instillation using a thin catheter, aerosolized or nebulized administration, and guided administration by supraglottic airway devices. One such method is surfactant administration through laryngeal or supraglottic airway, which involves placing a laryngeal mask without the need for laryngoscopy and administering surfactant through the device. The simplicity of laryngeal mask insertion could potentially streamline the surfactant delivery process, eliminating the necessity for advanced skills. This narrative review aimed to assess the current evidence in the literature regarding the benefits and risks associated with surfactant administration through a laryngeal supraglottic airway.

Keywords: Laryngeal mask, surfactant administration, SALSA, respiratory distress syndrome, newborn, preterm.

Graphical Abstract

[1]
Sweet DG, Carnielli VP, Greisen G, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update. Neonatology 2023; 120(1): 3-23.
[http://dx.doi.org/10.1159/000528914] [PMID: 36863329]
[2]
Polin RA, Carlo WA, Papile L-A, et al. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics 2014; 133(1): 156-63.
[http://dx.doi.org/10.1542/peds.2013-3443] [PMID: 24379227]
[3]
Kribs A, Roll C. Surfactant application via thin catheter: A practical guide. Neonatology 2019; 115(4): 326-35.
[http://dx.doi.org/10.1159/000499001]
[4]
Herting E, Härtel C, Göpel W. Less invasive surfactant administration (LISA): chances and limitations. Arch Dis Child Fetal Neonatal Ed 2019; 104(6): F655-9.
[http://dx.doi.org/10.1136/archdischild-2018-316557] [PMID: 31296694]
[5]
Dargaville PA, Kamlin COF, De Paoli AG, et al. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation. BMC Pediatr 2014; 14(1): 213.
[http://dx.doi.org/10.1186/1471-2431-14-213] [PMID: 25164872]
[6]
Brain AIJ. The laryngeal mask-a new concept in airway management. Br J Anaesth 1983; 55(8): 801-5.
[http://dx.doi.org/10.1093/bja/55.8.801] [PMID: 6349667]
[7]
Paterson SJ, Byrne PJ, Molesky MG, Seal RF, Finucane BT. Neonatal resuscitation using the laryngeal mask airway. Anesthesiology 1994; 80(6): 1248-53.
[http://dx.doi.org/10.1097/00000542-199406000-00012] [PMID: 8010471]
[8]
Mizushima A, Wardall GJ, Simpson DL. The laryngeal mask airway in infants. Anaesthesia 1992; 47(10): 849-51.
[http://dx.doi.org/10.1111/j.1365-2044.1992.tb03144.x] [PMID: 1443475]
[9]
Mani S, Pinheiro JMB, Rawat M. Laryngeal masks in neonatal resuscitation-a narrative review of updates 2022. Children 2022; 9(5): 733.
[http://dx.doi.org/10.3390/children9050733]
[10]
i-gel supraglottic airways. Available from: https://www.intersurgical.com/info/igel(accessed on 31-7-2024)
[11]
Barbieri E, Giordano M, Sorgente G, et al. Use and Efficacy of I-Gel in Complicated Intubations in Newborn Infants: A Review of Case Reports in the Literature. Curr Pediatr Rev 2024; 20
[http://dx.doi.org/10.2174/0115733963295361240426064436] [PMID: 38685776]
[12]
Galderisi A, De Bernardo G, Lorenzon E, Trevisanuto D. i-gel: a new supraglottic device for effective resuscitation of a very low birthweight infant with Cornelia de Lange syndrome. BMJ Case Rep 2015; 2015: bcr2014209124.
[http://dx.doi.org/10.1136/bcr-2014-209124] [PMID: 25809435]
[13]
Wyckoff MH, Aziz K, Escobedo MB, et al. Part 13: Neonatal Resuscitation. Circulation 2015; 132(18_suppl_2) (Suppl. 2): S543-60.
[http://dx.doi.org/10.1161/CIR.0000000000000267] [PMID: 26473001]
[14]
McPherson C, Wambach JA. Prevention and treatment of respiratory distress syndrome in preterm neonates. Neonatal Netw 2018; 37(3): 169-77.
[http://dx.doi.org/10.1891/0730-0832.37.3.169] [PMID: 29789058]
[15]
Capasso L, Pacella D, Migliaro F, De Luca D, Raimondi F. Can lung ultrasound score accurately predict the need for surfactant replacement in preterm neonates? A systematic review and meta-analysis protocol. PLoS One 2021; 16(7): e0255332.
[http://dx.doi.org/10.1371/journal.pone.0255332] [PMID: 34320032]
[16]
Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Libr 2012; 11(11): CD001456.
[http://dx.doi.org/10.1002/14651858.CD001456.pub2] [PMID: 23152207]
[17]
Perrone S, Giordano M, De Bernardo G, et al. Management of oxygen saturation monitoring in preterm newborns in the NICU: the Italian picture. Ital J Pediatr 2021; 47(1): 104.
[http://dx.doi.org/10.1186/s13052-021-01050-3] [PMID: 33941225]
[18]
Foglia EE, Ades A, Sawyer T, et al. Neonatal intubation practice and outcomes: an international registry study. Pediatrics 2019; 143(1): e20180902.
[http://dx.doi.org/10.1542/peds.2018-0902] [PMID: 30538147]
[19]
Maheshwari R, Tracy M, Badawi N, Hinder M. Neonatal endotracheal intubation: How to make it more baby friendly. J Paediatr Child Health 2016; 52(5): 480-6.
[http://dx.doi.org/10.1111/jpc.13192] [PMID: 27329901]
[20]
Donn SM, Sinha SK. Minimising ventilator induced lung injury in preterm infants. Arch Dis Child Fetal Neonatal Ed 2005; 91(3): F226-30.
[http://dx.doi.org/10.1136/adc.2005.082271] [PMID: 16632652]
[21]
Mokres LM, Parai K, Hilgendorff A, et al. Prolonged mechanical ventilation with air induces apoptosis and causes failure of alveolar septation and angiogenesis in lungs of newborn mice. Am J Physiol Lung Cell Mol Physiol 2010; 298(1): L23-35.
[http://dx.doi.org/10.1152/ajplung.00251.2009] [PMID: 19854954]
[22]
Mani S, Rawat M. Less Invasive Surfactant Administration: A Viewpoint. Am J Perinatol 2024; 41(2): 211-27.
[http://dx.doi.org/10.1055/a-2001-9139] [PMID: 36539205]
[23]
Wandita S. Newer technique in surfactant administration. Indonesian Journal of Perinatology 2023; 4(2): 44-9.
[http://dx.doi.org/10.51559/inajperinatol.v4i2.41]
[24]
Rong H, Bao Y, Wen Z, Chen X, Chen C, Li F. Nebulized versus invasively delivered surfactant therapy for neonatal respiratory distress syndrome. Medicine (Baltimore) 2020; 99(48): e23113.
[http://dx.doi.org/10.1097/MD.0000000000023113] [PMID: 33235071]
[25]
Devi U, Roberts KD, Pandita A. A systematic review of surfactant delivery via laryngeal mask airway, pharyngeal instillation, and aerosolization: Methods, limitations, and outcomes. Pediatr Pulmonol 2022; 57(1): 9-19.
[http://dx.doi.org/10.1002/ppul.25698] [PMID: 34559459]
[26]
Brimacombe J, Gandini D, Keller C. The laryngeal mask airway for administration of surfactant in two neonates with respiratory distress syndrome. Paediatr Anaesth 2004; 14(2): 188-90.
[http://dx.doi.org/10.1046/j.1460-9592.2003.01173.x] [PMID: 14962337]
[27]
Trevisanuto D, Grazzina N, Micaglio M. Laryngeal mask airway as a delivery channel for administration of surfactant in preterm infants with RDS. Pediatric Academic Societies’ Annual Meeting. San Francisco, California, 1–4 May 2004. Pediatr Res 2004; 55: 515A.
[28]
Micaglio M, Zanardo V, Ori C, Parotto M, Doglioni N, Trevisanuto D. ProSeal LMA for surfactant administration. Paediatr Anaesth 2008; 18(1): 91-2.
[http://dx.doi.org/10.1111/j.1460-9592.2007.02371.x] [PMID: 18095983]
[29]
Barbosa RF, Marcatto JO, Silva AC, Silva YP. ProSealTM laryngeal mask airway for surfactant administration in the treatment of respiratory distress syndrome in a premature infant. Rev Bras Ter Intensiva 2012; 24(2): 207-10.
[http://dx.doi.org/10.1590/S0103-507X2012000200018] [PMID: 23917771]
[30]
Kaushal M, Asghar S, Ayush K, Augustine P, Alex M. Surfactant administration through laryngeal supraglottic airway (SALSA): A unique and new technique of surfactant administration. Edorium J Matern Child Health 2020; 5: 100008M01MK2020.
[31]
Smee NJ, Boyd D, Conetta H, O’Shea J. Laryngeal mask airway surfactant administration: case series of 60 infants. Arch Dis Child Fetal Neonatal Ed 2021; 106(3): 342.
[http://dx.doi.org/10.1136/archdischild-2020-320438] [PMID: 33246968]
[32]
Parmigiani S, Consigli V, Suriano G, Stretti MT, Corona MF, Gerali A. Administration of endotracheal surfactant via laryngeal mask: eight cases. Acta Paediatr 2010; 99(S462): 100.
[33]
Roberts KD, Brown R, Lampland AL, et al. Laryngeal Mask Airway for Surfactant Administration in Neonates: A Randomized, Controlled Trial. J Pediatr 2018; 193: 40-46.e1.
[http://dx.doi.org/10.1016/j.jpeds.2017.09.068] [PMID: 29174079]
[34]
Sadeghnia A, Tanhaei M, Mohammadizadeh M, Nemati M. A comparison of surfactant administration through i-gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams. Adv Biomed Res 2014; 3(1): 160.
[http://dx.doi.org/10.4103/2277-9175.137875] [PMID: 25221763]
[35]
Pinheiro JMB, Santana-Rivas Q, Pezzano C. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery. J Perinatol 2016; 36(3): 196-201.
[http://dx.doi.org/10.1038/jp.2015.177] [PMID: 26633145]
[36]
Gharehbaghi M, Moghaddam YJ, Radfar R. Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome. Crescent J Med Biol Sci 2018; 5(3): 222-7.
[37]
Barbosa RF, Simões e Silva AC, Silva YP. A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates. J Pediatr (Rio J) 2017; 93(4): 343-50.
[http://dx.doi.org/10.1016/j.jped.2016.08.007] [PMID: 28130967]
[38]
Amini E, Sheikh M, Shariat M, Dalili H, Azadi N, Nourollahi S. Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial. Acta Med Iran 2019; 57(6): 348-54.
[http://dx.doi.org/10.18502/acta.v57i6.1877]
[39]
Gallup JA, Ndakor SM, Pezzano C, Pinheiro JMB. Randomized Trial of Surfactant Therapy via Laryngeal Mask Airway versus Brief Tracheal Intubation in Neonates Born Preterm. J Pediatr 2023; 254: 17-24.e2.
[http://dx.doi.org/10.1016/j.jpeds.2022.10.009] [PMID: 36241051]
[40]
Stewart C, Stukenborg G, Kattwinkel J, Attridge J. Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial. Am J Perinatol 2012; 30(3): 201-6.
[http://dx.doi.org/10.1055/s-0032-1323592] [PMID: 22893557]
[41]
Abu Leyah NAA, Hasan AA, Juneau JN. Implementation of Surfactant Administration through Laryngeal or Supraglottic Airways (SALSA): A jordanian NICU's journey to improve surfactant administration. Children 2022; 9(8): 1147.
[http://dx.doi.org/10.3390/children9081147]
[42]
Trial registered on ANZCTR. 2020. Available from:https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380574&isReview=true(accessed on 31-7-2024)
[43]
Wanous AA, Wey A, Rudser KD, Roberts KD. Feasibility of laryngeal mask airway device placement in neonates. Neonatology 2017; 111(3): 222-7.
[http://dx.doi.org/10.1159/000450691] [PMID: 27866188]
[44]
Zapata HA, Fort P, Roberts KD, Kaluarachchi DC, Guthrie SO. Surfactant Administration Through Laryngeal or Supraglottic Airways (SALSA): A viable method for low-income and middle-income countries. Front Pediatr 2022; 10: 853831.
[http://dx.doi.org/10.3389/fped.2022.853831]